All In Biotech

Drug Trial Radar · NCT06617715

Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine

A Phase Ⅲ Clinical Study to Evaluate the Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Healthy Infants

Last checked: Nov 19, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 3,080 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

3,080

Planned (sponsor's estimate)

Start

Oct 23, 2024

Primary completion

May 12, 2026

Study completion Jul 30, 2026

Sponsor

Sponsor type
Industry
First posted
Sep 27, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 6 weeks, up to 5 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Phase Ⅲ clinical trial of 13-valent pneumococcal conjugate vaccine (PCV13) developed by Sinovac Life Science Co., Ltd will be conducted in pediatric population aged 2 months (minimum 6 weeks)-5 years (before 6th birthday). The objective of the study is to evaluate the immunogenicity and safety of Sinovac PCV13.

Conditions

  • Pneumococcal Infectious Disease

Interventions

  • Sinovac PCV13Biological

    One dose of Sinovac PCV13 (0.5 mL) is administered intramuscularly.

  • Prevnar®Biological

    One dose of Prevnar® (0.5 mL) is administered intramuscularly.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of pneumococcal serotype-specific IgG antibody concentration ≥0.35 μg/ml (seropositive rate)Time frame: 30 days after primary vaccination
  2. Pneumococcal serotype-specific IgG antibody geometric mean concentration (GMC)Time frame: 30 days after primary vaccination

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Henan Provincial Center for Disease Control and Prevention

    Zhengzhou, Henan, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.